Novartis (Tobradex ST and Natacyn) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Novartis (Tobradex ST and Natacyn) General Information

Description

Portfolio of antibiotics. The antibiotics include Tobradex ST (tobramycin/dexamethasone ophthalmic suspension) 0.3%/0.05% and Natacyn (natamycin ophthalmic suspension) 5%.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Switzerland
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Eyevance Pharmaceuticals
Corporate Office
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novartis (Tobradex ST and Natacyn) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novartis (Tobradex ST and Natacyn)‘s full profile, request access.

Request a free trial

Novartis (Tobradex ST and Natacyn) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novartis (Tobradex ST and Natacyn)‘s full profile, request access.

Request a free trial

Novartis (Tobradex ST and Natacyn) FAQs

  • Where is Novartis (Tobradex ST and Natacyn) headquartered?

    Novartis (Tobradex ST and Natacyn) is headquartered in Switzerland.

  • What industry is Novartis (Tobradex ST and Natacyn) in?

    Novartis (Tobradex ST and Natacyn)’s primary industry is Buildings and Property.

  • Is Novartis (Tobradex ST and Natacyn) a private or public company?

    Novartis (Tobradex ST and Natacyn) is a Private company.

  • What is Novartis (Tobradex ST and Natacyn)’s current revenue?

    The current revenue for Novartis (Tobradex ST and Natacyn) is .

  • Who are Novartis (Tobradex ST and Natacyn)’s investors?

    Novartis has invested in Novartis (Tobradex ST and Natacyn).

  • When was Novartis (Tobradex ST and Natacyn) acquired?

    Novartis (Tobradex ST and Natacyn) was acquired on 16-Oct-2019.

  • Who acquired Novartis (Tobradex ST and Natacyn)?

    Novartis (Tobradex ST and Natacyn) was acquired by Eyevance Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process